Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 1

1(16.7%)

Phase 4

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 1(1)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07257003Not ApplicableNot Yet Recruiting

A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy

Role: collaborator

NCT02966483Not ApplicableRecruiting

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Role: collaborator

NCT06524622Recruiting

VExUS Combined With CVP to Predict Clinical Outcomes in Sepsis Participants

Role: lead

NCT05730595Not ApplicableNot Yet Recruiting

Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Role: collaborator

NCT02971345Phase 3Unknown

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Role: collaborator

NCT03472352Phase 1Unknown

Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors

Role: collaborator

NCT00548223Phase 4Completed

The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule

Role: collaborator

All 7 trials loaded